Waddinxveen (NL) — INTEGRA Biosciences Group, a leading provider of laboratory tools for liquid handling and media preparation based in Switzerland, is buying shares in CleanNA, an established reagent manufacturer based in the Netherlands. This initial investment will cement a long-term strategic collaboration between the two companies, with a view to expanding CleanNA’s global reach and […]
First commercially available NK (natural killer) cell-specific promoter library enables precise and controllable gene expression Portfolio of synthetic promoters validates SynGenSys’ platform for engineering targeted, tissue-specific gene regulation control elements Sheffield, UK — SynGenSys, a biotechnology company designing synthetic gene promoter systems to address critical bottlenecks in biopharma manufacturing and enhance cell and gene therapy development, […]
Illumina and pharma partners will develop companion diagnostics for historically important KRAS biomarker SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) will partner with multiple global pharmaceutical companies to develop companion diagnostics (CDx) enabled on the TruSight™ Oncology (TSO) Comprehensive genomic profiling test. The continued expansion of tumor-agnostic CDx claims underscores Illumina’s commitment to advance access for […]
SALT LAKE CITY and BOSTON — Myriad Genetics (Nasdaq: MYGN), a leader in molecular diagnostic testing and precision medicine, and SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, announced a strategic collaboration to develop and provide pharmaceutical companies with an innovative global liquid biopsy companion diagnostic (CDx) test. This partnership will leverage Myriad’s advanced laboratory capabilities in the […]
Introduction Monoclonal antibodies (mAbs) remain one of the most widely used therapeutic modalities across oncology, autoimmune diseases, and infectious diseases. In upstream development, accurate and timely measurement of mAb concentration is essential for clone selection, process optimisation, and early screening workflows. Conventional techniques such as enzyme-linked immunosorbent assays (ELISA) and conventional high-performance liquid chromatography (HPLC) […]
ZEISS and Concept Life Sciences announce partnership Jena, Germany | ZEISS Research Microscopy Solutions — ZEISS Microscopy and Concept Life Sciences, a UK-based contract research organization (CRO), announced their collaboration aimed at pioneering new approaches to workflow automation and scalable image analysis in spatial biology. Key focus areas of the collaboration are: Automated high-throughput imaging […]
BOSTON — SOPHiA GENETICS (Nasdaq: SOPH), an AI technology company transforming precision medicine, today announced an expansion of its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN) from the World CB & CDx Summit in Boston. The companies aim to improve the diagnosis and treatment of breast and prostate cancer by developing an optimized next generation sequencing (NGS) solution that leverages SOPHiA GENETICS’s AI […]
Combination of Revvity’s proprietary Pin-point platform and Profluent’s AI-engineered proteins created to inspire accelerated development of novel gene editing therapies WALTHAM, Mass. — Revvity, Inc. (NYSE: RVTY) announced a strategic collaboration with Profluent, bringing together a range of its novel AI-engineered enzymes with Revvity’s established Pin-pointTM base editing platform. The result is simplified access for customers to a therapeutically […]
ROCKVILLE, Md. — MaxCyte, Inc., (Nasdaq: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the discovery, development and commercialization of next-generation cell therapeutics, today announced a restructuring of its operations to better align resources with its strategic priorities. This plan includes a reduction of approximately 34% of the Company’s global workforce, […]
New GMP facility for transfection reagents of French sub-group Sartorius Stedim Biotech in Illkirch Facility equipped to support next-generation technologies in cell and gene therapies Göttingen, Germany — The life science group Sartorius has expanded the site of its French sub-group Sartorius Stedim Biotech in Illkirch, near Strasbourg. The state-of-the-art facility adds pharmaceutical-grade (GMP) production […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
